Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Landmark detailed analysis of the cranium and mandibular phenotypes in Dp(16)1Yey. by José Tomás Ahumada Saavedra (22290934)

“…(B) Form difference matrix analysis: FDM Bootstrap with 10,000 iterations showing significant changes in Form (p = 0.008). The FDM confidence interval graph shows a decrease of more than 90% of the distances measured. …”

Eligibility criteria. by Keean Nanji (16516622)

“…</p><p>Discussion</p><p>The results of this NMA will provide a comprehensive evaluation of the evidence for this critical question with significant clinical equipoise.…”

PRR expression in platelets and leukocytes and their changes with SARS-CoV-2 infection. by Heather Learnard (22075952)

Table 1_Differential effects of prophylactic iron supplementation on physiological gestational anemia and post-IDA gestational anemia: a study based on a rat model.docx by Zelin Zhang (1563172)

“…Objective<p>To observe the effects of iron supplementation on a physiological pregnancy and on pregnancy following iron deficiency anemia (IDA) caused by low-iron diet.…”

Data extraction. by Stefanie Lentner (21493018)

“…The detrimental impacts of decreased occupational balance are increasingly acknowledged, and interventions are emerging. …”

Characteristics of included studies. by Stefanie Lentner (21493018)

“…The detrimental impacts of decreased occupational balance are increasingly acknowledged, and interventions are emerging. …”

Low levels of platelet-specific transcripts in leukocytes can be due to platelet-leukocyte interactions. by Heather Learnard (22075952)

(a) Cement; (b) SHMP; (c) Water glass; (d) PG. by Chenhao Li (822769)

“…Although increasing SHMP content improved the early strength, it led to a decrease in later strength, with the maximum late strength observed at 2% SHMP. …”

Age-standardized hepatocellular carcinoma (HCC) incidence rates, by viral hepatitis status, the surveillance, epidemiology, and end results–medicare database, 2007–2017. by Joy Jiang (5483006)

Loxoprofen or SB225002 administration attenuated inflammatory pain in complete Freund’s adjuvant (CFA)-injected mice exposed to sound stress. by Satoka Kasai (3861115)

“…<b>(A)</b> Loxoprofen administration (500 mg/kg) significantly decreased the response times to filament in CFA + saline group 60 min after administration (***<i>P</i> < 0.001), and in CFA + stress + saline group (30 and 60 min after administration, **<i>P</i> < 0.01). …”

The effect of IE2 on macrophage stimulated T cell differentiation. by Xianjuan Zhang (11630062)

Comparative analysis of PRRs and select transcripts related to thrombosis, coagulation and platelet-leukocyte interactions across three respiratory infections, COVID19, influenza a... by Heather Learnard (22075952)